Iovance Biotherapeutics Statistics
Total Valuation
IOVA has a market cap or net worth of $654.96 million. The enterprise value is $406.94 million.
Important Dates
The next confirmed earnings date is Thursday, November 6, 2025, before market open.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
IOVA has 361.85 million shares outstanding. The number of shares has increased by 20.18% in one year.
| Current Share Class | 361.85M |
| Shares Outstanding | 361.85M |
| Shares Change (YoY) | +20.18% |
| Shares Change (QoQ) | +3.61% |
| Owned by Insiders (%) | 8.10% |
| Owned by Institutions (%) | 53.20% |
| Float | 303.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.37 |
| Forward PS | 1.91 |
| PB Ratio | 0.89 |
| P/TBV Ratio | 1.63 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.68 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.27, with a Debt / Equity ratio of 0.08.
| Current Ratio | 3.27 |
| Quick Ratio | 2.80 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -53.16% and return on invested capital (ROIC) is -32.04%.
| Return on Equity (ROE) | -53.16% |
| Return on Assets (ROA) | -27.42% |
| Return on Invested Capital (ROIC) | -32.04% |
| Return on Capital Employed (ROCE) | -52.76% |
| Revenue Per Employee | $288,216 |
| Profits Per Employee | -$465,300 |
| Employee Count | 838 |
| Asset Turnover | 0.26 |
| Inventory Turnover | 4.94 |
Taxes
In the past 12 months, IOVA has paid $188,000 in taxes.
| Income Tax | 188,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -84.18% in the last 52 weeks. The beta is 0.85, so IOVA's price volatility has been lower than the market average.
| Beta (5Y) | 0.85 |
| 52-Week Price Change | -84.18% |
| 50-Day Moving Average | 2.19 |
| 200-Day Moving Average | 2.96 |
| Relative Strength Index (RSI) | 33.97 |
| Average Volume (20 Days) | 14,892,703 |
Short Selling Information
The latest short interest is 83.61 million, so 23.11% of the outstanding shares have been sold short.
| Short Interest | 83.61M |
| Short Previous Month | 72.97M |
| Short % of Shares Out | 23.11% |
| Short % of Float | 27.54% |
| Short Ratio (days to cover) | 7.87 |
Income Statement
In the last 12 months, IOVA had revenue of $241.53 million and -$389.92 million in losses. Loss per share was -$1.23.
| Revenue | 241.53M |
| Gross Profit | 49.75M |
| Operating Income | -410.64M |
| Pretax Income | -389.73M |
| Net Income | -389.92M |
| EBITDA | -376.29M |
| EBIT | -410.64M |
| Loss Per Share | -$1.23 |
Full Income StatementBalance Sheet
The company has $301.18 million in cash and $53.17 million in debt, giving a net cash position of $248.02 million or $0.69 per share.
| Cash & Cash Equivalents | 301.18M |
| Total Debt | 53.17M |
| Net Cash | 248.02M |
| Net Cash Per Share | $0.69 |
| Equity (Book Value) | 698.49M |
| Book Value Per Share | 2.04 |
| Working Capital | 293.35M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$303.41 million and capital expenditures -$20.13 million, giving a free cash flow of -$323.54 million.
| Operating Cash Flow | -303.41M |
| Capital Expenditures | -20.13M |
| Free Cash Flow | -323.54M |
| FCF Per Share | -$0.89 |
Full Cash Flow StatementMargins
Gross margin is 20.60%, with operating and profit margins of -170.02% and -161.44%.
| Gross Margin | 20.60% |
| Operating Margin | -170.02% |
| Pretax Margin | -161.36% |
| Profit Margin | -161.44% |
| EBITDA Margin | -155.80% |
| EBIT Margin | -170.02% |
| FCF Margin | n/a |
Dividends & Yields
IOVA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -20.18% |
| Shareholder Yield | -20.18% |
| Earnings Yield | -59.53% |
| FCF Yield | -49.40% |
Dividend DetailsAnalyst Forecast
The average price target for IOVA is $10.80, which is 496.69% higher than the current price. The consensus rating is "Buy".
| Price Target | $10.80 |
| Price Target Difference | 496.69% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | 42.97% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 26, 2013. It was a reverse split with a ratio of 1:100.
| Last Split Date | Sep 26, 2013 |
| Split Type | Reverse |
| Split Ratio | 1:100 |
Scores
IOVA has an Altman Z-Score of 0.95 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.95 |
| Piotroski F-Score | 3 |
